RT-105

N/A

Report date: 2023/03/10 14:59:16

Base Information

Drug NameRT-105
Drug Alias NameRT-105
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLiver Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Royaltech Med Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Royaltech Med Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLiver Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A